Pricing Log in Create free account
Saturday 17 October 2026 Export PACS’s income statement to Excel — free account

PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

46.91 0.84 −1.76%
Market cap
$7.6B
P/E
27.6×
Fwd P/E
16.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.50
Total sells 84.95
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 1 — — — — — — — — — — —
Sell 1 — — — 1 — 1 4 5 4 5 2
Insider Ownership 71.22%

Capital & Financial Ratios $m

Market Cap 7,560.00
Revenue 5,551.04
Net Income 269.13
Free Cash Flow 456.53
Net Debt 81.64
Current Ratio 0.91 (below 1: weak)
Debt/Equity 0.22 (at or below 0.5: strong)
P/E ratio 27.59
Fwd P/E 16.80
P/S ratio 1.34
P/B ratio 6.65 (above 6: high)
Past 5Y EPS Growth —
This Y EPS Growth 32.37% (at or above 15%: strong)
Next Y EPS Growth 10.69%
Next Y revenue growth 10.51% (at or above 10%: strong)
Next 5Y EPS Growth 17.00% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.4×, against a ten-year median of 1.0×; over the ten years it ranged from 0.3× in 2025 to 1.8× in 2024.

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2026 Powerpack
2025 Powerpack
2024 Powerpack
2023 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 73 158 197 164
Receivables 600 717 702 724
Inventory — — — —
Other — — — —
722 938 1,070 962
2023 2024 2025 Q'26
Payables 141 175 192 161
ST’ Debt 17 15 4 7
Other — 146 181 181
457 978 1,001 1,055

Compound Annual Growth %

10y 5y 3y
Sales — — 29.74%
Cash Flow — — 63.42%
Earnings — — 8.37%
Book Value — — 140.29%

Revenue $m

Mar Jun Sep Dec Year
’26 1,420 1,428 — — —
’25 1,277 1,309 1,345 1,358 5,289
’24 920 936 1,026 1,208 4,090
’23 708 761 789 853 3,111
’22 — — — — 2,422
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 236 136 — — —
’25 150 53 205 (3) 404
’24 59 35 209 65 367
’23 79 (21) 15 (10) 64
’22 — — — 93 93
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 215 109 — — —
’25 133 34 187 (54) 300
’24 48 19 195 40 302
’23 73 (31) 1 (25) 19
’22 — — — 70 70
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.50 0.47 — — —
’25 0.17 0.31 0.32 0.43 1.22
’24 0.27 (0.21) 0.10 0.25 0.38
’23 0.29 0.16 0.15 0.27 0.88
’22 — — — — 1.17
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — — — 12.54 7.50

Analyst estimates 2026–2028

Powerpack
High — — — — — — — — 43.92 40.09
People
People Employees — — — — — — — 32,433 45,680 47,455
Revenue/emp, $m — — — — — 0.00 0.00 0.10 0.09 0.11
Income, $m
Income, $m Revenue — — — — — 1,167 2,422 3,111 4,090 5,289
Gross margin, % — — — — — 16.06 16.54 14.37 12.41 14.75
EBT — — — — — 81 207 157 102 284
EBT margin, % — — — — — 6.98 8.55 5.06 2.48 5.38
Net income — — — — — 48 150 113 55 191
Depreciation — — — — — 8 24 32 44 59
Per share, $
Per share, $ Revenue — — — — — 9.06 18.82 24.17 27.89 33.86
Earnings — — — — — 0.37 1.17 0.88 0.38 1.23
Cash flow — — — — — 0.45 0.72 0.49 2.50 2.59
Capex — — — — — (0.96) (0.18) (0.35) (0.44) (0.67)
Free cash flow — — — — — (0.52) 0.54 0.15 2.06 1.92
Book value — — — — — 0.00 0.53 0.79 4.88 6.10
Shares, m — — — — — 129 129 129 147 156
Valuation, ×
Valuation, × P/E — — — — — 26.89 26.89 26.89 32.20 31.47
P/S — — — — — 0.89 0.89 0.89 0.47 1.13
P/B — — — — — 22.16 22.16 22.16 2.69 6.30
EV/Sales — — — — — 1.10 1.10 1.10 0.50 1.16
EV/FCF — — — — — (546.96) (546.96) (546.96) 6.72 20.52
Cash, $m
Cash, $m Operating cash flow — — — — — 58 93 64 367 404
Capex — — — — — (124) (23) (45) (65) (105)
Free cash flow — — — — — (66) 70 19 302 300
Balance, $m
Balance, $m Working capital — — — — — — 27 265 (40) 68
Total debt — — — — — — 500 733 266 349
Net debt — — — — — — 441 659 108 152
Shareholders’ equity — — — — — — 69 102 716 952
Returns, %
Returns, % ROA — — — — — 0.00 12.23 3.78 1.27 3.54
ROIC — — — — — 0.00 28.10 17.07 9.34 17.52
ROE — — — — — 0.00 0.00 132.50 13.64 22.96
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

PACS Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DVA DaVita Inc. $12.1B 15.0× 13.1× +5.17% (above 0%: growing) +56.49% (above 0%: growing) +49.36% (above 0%: growing) 32.70% 16.29% Compare
FMS Fresenius Medical Care AG & Co. KGaA $11.8B 11.5× 12.5× +3.89% (above 0%: growing) +6.82% (above 0%: growing) +1.57% (above 0%: growing) 26.95% 9.58% Compare
UHS Universal Health Services, Inc. $11.0B 7.5× 6.1× +8.27% (above 0%: growing) +9.47% (above 0%: growing) −23.78% (below 0%: shrinking) 90.87% 11.14% Compare
ENSG The Ensign Group, Inc. $10.4B 26.9× 24.1× +17.33% (above 0%: growing) +16.22% (above 0%: growing) +12.24% (above 0%: growing) 16.65% 8.50% Compare
PACS PACS Group, Inc. $7.6B 27.6× 16.8× +9.07% (above 0%: growing) +45.45% (above 0%: growing) +220.51% (above 0%: growing) 17.07% 7.66%
CHE Chemed Corporation $6.7B 25.7× 20.4× +8.80% (above 0%: growing) +42.78% (above 0%: growing) −43.51% (below 0%: shrinking) 32.90% 13.25% Compare
CON Concentra Group Holdings Parent, Inc. $5.0B 24.9× 17.0× +10.03% (above 0%: growing) +45.71% (above 0%: growing) +91.62% (above 0%: growing) 31.70% 18.99% Compare
LFST LifeStance Health Group, Inc. $4.7B 88.3× 58.5× +26.08% (above 0%: growing) n/m +55.22% (above 0%: growing) 35.15% 7.04% Compare
OPCH Option Care Health, Inc. $4.7B 23.5× 14.1× +1.86% (above 0%: growing) +12.90% (above 0%: growing) +112.36% (above 0%: growing) 18.53% 5.90% Compare
Median of peers $8.6B 24.2× 15.6× +8.54% +16.22% +30.80% 32.20% 10.36%

All 55 Medical Care Facilities stocks →

PACS Group, Inc. (PACS) key facts

  • Strength: PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
  • PACS Group, Inc. (PACS) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, PACS traded at $46.91, a market capitalization of $7.6 billion.
  • Return on equity was 23.0% and debt-to-equity 0.22.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.00 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

PACS Group, Inc. (PACS) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/PACS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com